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SHORT REPORT
p300-mediated acetylation of COMMD1 regulates its stability,
and the ubiquitylation and nucleolar translocation of the RelA
NF-kB subunit
Andrew O’Hara1, James Simpson1, Pierre Morin1, Carolyn J. Loveridge1, Ann C. Williams2, Sonia M. Novo1 and
Lesley A. Stark1,*
ABSTRACT
Nucleolar sequestration of the RelA subunit of nuclear factor (NF)-
kB is an important mechanism for regulating NF-kB transcriptional
activity. Ubiquitylation, facilitated by COMMD1 (also known as
MURR1), acts as a crucial nucleolar-targeting signal for RelA, but
how this ubiquitylation is regulated, and how it differs from cytokine-
mediated ubiquitylation, which causes proteasomal degradation of
RelA, is poorly understood. Here, we report a new role for p300
(also known as EP300) in controlling stimulus-specific ubiquitylation
of RelA, through modulation of COMMD1. We show that p300
is required for stress-mediated ubiquitylation and nucleolar
translocation of RelA, but that this effect is indirect. We also
demonstrate that COMMD1 is acetylated by p300 and that
acetylation protects COMMD1 from XIAP-mediated proteosomal
degradation. Furthermore, we demonstrate that COMMD1
acetylation is enhanced by aspirin-mediated stress, and that this
acetylation is absolutely required for the protein to bind RelA under
these conditions. In contrast, tumour necrosis factor (TNF) has no
effect on COMMD1 acetylation. Finally, we demonstrate these
findings have relevance in a whole tissue setting. These data offer a
new paradigm for the regulation of NF-kB transcriptional activity,
and the multiple other pathways controlled by COMMD1.
KEY WORDS: Aspirin, Chemoprevention, NF-kB, Apoptosis,
Acetylation, Nucleoli, Nucleolus, COMMD1, p300, XIAP
INTRODUCTION
The nuclear factor (NF)-kB transcription factor plays a central
role in many processes, including inflammation and stress
response (Perkins and Gilmore, 2006). The most recognised
mechanism for regulating its activity is cytoplasmic to nuclear
translocation (Karin, 1999). However, once in the nucleus, NF-
kB is modulated by a plethora of co-activators, repressors and
post-transcriptional modifications (Huang et al., 2010; Yang
et al., 2010). These nuclear regulatory pathways are important
because they determine the downstream consequences of
stimulating NF-kB. However, they remain poorly understood.
One mechanism that regulates NF-kB activity in the nucleus is the
distribution of the RelA (also known as p65) subunit (Loveridge et al.,
2008; Stark and Dunlop, 2005). Inflammatory cytokines, such as
tumour necrosis factor (TNF), cause nucleoplasmic accumulation of
RelA, which activates NF-kB-driven transcription (Perkins and
Gilmore, 2006), whereas specific stress stimuli (including UV-C
radiation, serum deprivation and aspirin) cause nucleolar accumulation
of RelA, which represses NF-kB-driven transcription (Khandelwal
et al., 2011; Stark and Dunlop, 2005; Thoms et al., 2007).
Understanding of the pathways that regulate RelA nuclear
distribution is limited, but work from our group has previously
identified ubiquitylation as crucial (Thoms et al., 2010). We have
demonstrated that stress stimuli cause polyubiquitylation of RelA
and increased levels of the ubiquitin ligase co-factor COMMD1.
Furthermore, we have demonstrated that COMMD1-facilitated
ubiquitylation is essential for nucleoplasmic–nucleolar translocation
of RelA. TNF also induces COMMD1-dependent RelA
ubiquitylation, but this targets the protein for degradation rather
than nucleolar translocation, suggesting that different ubiquitylation
pathways and/or signatures might be involved (Colleran et al., 2013;
Saccani et al., 2004).
Acetylation also plays an essential role in regulating nuclear
RelA (Chen and Greene, 2004) and previous studies have suggested
that this inhibits TNF-mediated ubiquitylation (Li et al., 2012).
However, the role of acetylation and deacetylation in stress-induced
ubiquitylation and nucleolar translocation of RelA is unknown.
Here, we report that an acetylation event does regulate the
nucleolar translocation of RelA. We report that p300 (also known
as EP300) acetylates COMMD1 and that this acetylation protects it
from degradation. We also demonstrate that COMMD1 acetylation
is enhanced in response to aspirin-mediated stress, and that this
acetylation is required for the subsequent interaction with RelA. In
contrast, TNF has no effect on COMMD1 acetylation. These data
not only have relevance to the regulation of nuclear NF-kB
activity, but also to the multiple other pathways modulated by the
pleotropic protein COMMD1.
RESULTS AND DISCUSSION
p300 is required for the ubiquitylation and nucleolar
translocation of RelA
Previous reports have suggested that RelA deacetylation is a pre-
requisite for TNF-mediated ubiquitylation (Li et al., 2012).
However, here, we found that aspirin-mediated ubiquitylation of
RelA (aspirin is used as a model stress stimuli) is paralleled by
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increased acetylation of RelA and increased binding to the
acetyltransferase p300 (Fig. 1A,B). We also found that
p300 depletion abrogated aspirin-mediated ubiquitylation and
nucleoplasmic to nucleolar translocation of RelA (Fig. 1C–F).
However, site-directed mutagenesis revealed that all the
identified p300 acetylation sites (K122, K123, K218 K221 and
K310) within the first 311 amino acids of RelA [the minimal
required for nucleolar localisation (Stark and Dunlop, 2005)] are
dispensable for nucleolar transport of the protein (Fig. 1G–H).
These data would suggest that p300 is essential for the
ubiquitylation of RelA associated with nucleolar translocation,
but that this effect is indirect. As K310 and K123 are required for
TNF-mediated ubiquitylation, the data would also suggest that the
lysine residues important for stress and cytokine response differ
(Li et al., 2012). Work is currently underway to define RelA
residues required for stress-mediated ubiquitylation and nucleolar
translocation of RelA. Here, we focus on essential acetylation
events.
Fig. 1. p300 is required for the ubiquitylation and nucleolar translocation of RelA. (A,B) SW480-GFP-RelA cells were exposed to 0 (2) or 5 mM (+)
aspirin (Asp, 16 h), RelA was immunoprecipitated (IP), then recovered proteins were analysed by immunoblot (WB) for (A) acetylated RelA (AcRelA; anti-
AcRelAK310 antibody) or (B) p300. Stripped gels were re-probed for RelA. Input levels of protein are shown. Rabbit IgG acts as a control. (C–F) SW480 cells
were transfected with control (scrambled) or p300 siRNA, then treated with aspirin (C,D, 10 mM, times indicated; E,F, 5 mM, 16 h). (C) Immunoblot for
p300. (D) Cells were co-transfected with His6–ubiquitin. Ubiquitylated RelA was analysed in lysates using nickel (Ni) agarose bead precipitation and
immunoblotting for RelA. (E,F) Immunomicrographs demonstrating the localisation of RelA. The arrow indicates a nucleolus. The number of cells showing nucleolar
RelA was determined in .200 cells from more than five fields. Data shown are the mean6s.e.m. n53. *P,0.05 (Student’s t-test). (G,H) Diagram showing p300
acetylated lysine residues that were mutated to arginine residues. Live-cell imaging demonstrates nucleolar localisation of mutants. Scale bar: 10 mm.
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p300 acetylates COMMD1 and regulates the stability of
the protein
Instead of RelA, we considered the possibility that p300
modulates COMMD1. Indeed, immunoprecipitation indicated
that COMMD1 interacts with p300, that this interaction is greatly
enhanced upon aspirin exposure (despite a decrease in total
cellular levels of p300) and that this is associated with COMMD1
acetylation (Fig. 2A,B). To determine the role of this acetylation
in nucleolar transport of RelA we firstly utilised a small
interfering RNA (siRNA) approach. Surprisingly, we found that
depletion of p300 alone caused a substantial reduction in basal
and induced levels of COMMD1 (Fig. 2C) and thus, abrogated
Fig. 2. p300 acetylates and regulates the stability of COMMD1. (A,B,D) SW480 cells were transfected with COMMD–GST or GST alone (A,B), or
together with control or p300 siRNA (D). Following aspirin (Asp) (10 mM, indicated times) treatment, GST-tagged proteins were isolated from whole-cell lysates
using glutathione–agarose. Precipitated proteins were subjected to western blotting (WB) for (A) p300, (B) acetylated (Ac) lysine or (D) RelA. Gels were re-
probed with GST to confirm equal GST–COMMD1 pulldown. (A,D) Input levels of indicated proteins are shown. Control, non-specific band. (C,E,F) Cells were
transfected with control, p300 or p300b siRNA then (C,E) treated with aspirin (10 mM) for indicated times or (F) co-transfected with the plasmids
indicated. Immunoblots show COMMD1 and p300 levels. Actin controls for loading. (G) Cells were transfected with control or p300 siRNA, treated with aspirin
(5 mM, 16 h) then RNA was isolated. Real-time PCR was used to quantify COMMD1 transcripts relative to GAPDH control. The mean6s.e.m of three
independent experiments is shown.
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the COMMD1–RelA interaction (Fig. 2D). Use of an
independent siRNA confirmed the substantial depletion of
COMMD1 upon p300 knockdown (Fig. 2E). Furthermore,
overexpression studies indicated this could be rescued by
expression of wild-type p300, but not an acetylation defective
mutant [deleted for the histone acetyltransferase domain
(DHAT)] (Dornan et al., 2004) (Fig. 2F).
Given that p300 acts as a transcriptional co-activator, we
considered it might be required for COMMD1 transcription.
However, qRT-PCR indicated p300 depletion had no significant
effect on COMMD1 mRNA levels, and that aspirin caused a
decrease in COMMD1 mRNA, despite causing an increase in
cellular levels of the protein (Fig. 2F). Hence, we concluded that
p300 and aspirin influence COMMD1 stability.
In addition to regulation of NF-kB, COMMD1 has a number of
other important functions. These include Cu2+ and Na+ transport,
cell proliferation and adaptation to hypoxia (Bartuzi et al., 2013).
In keeping with these roles, mice null for COMMD1 show
embryonic lethality and dysregulation of COMMD1 is associated
with diseases such as copper toxicosis and cancer (Li et al.,
2014; Sarkar and Roberts, 2011; van de Sluis et al., 2010).
Hence, pathways that control COMMD1 activity are extremely
interesting. Identified mechanisms of regulation include cytoplasmic–
nuclear shuttling, mRNA stability (Muller et al., 2007) and
proteasomal degradation (Burstein et al., 2004). This is the first
demonstration that COMMD1 is regulated by acetylation, and so
warranted further investigation.
Acetylation and deacetylation regulates XIAP-mediated
degradation of COMMD1
Previous studies have indicated COMMD1 is ubiquitylated by
the E3 ligase XIAP, then targeted for degradation (Mufti et al.,
2007). Therefore, we next determined whether this pathway was
involved in COMMD1 regulation by p300. Fig. 3A demonstrates
that the reduction in COMMD1 observed upon loss of p300 is
reversed by concomitant depletion of XIAP.
These exciting data would suggest that there is competition
between COMMD1 acetylation and ubiquitylation. If so, we
would expect acetylated COMMD1 levels to increase upon XIAP
knockdown. However, XIAP depletion did not increase either
basal or induced COMMD1 acetylation, despite increasing
absolute COMMD1 levels (Fig. 3B). This finding suggests
COMMD1 is both acetylated and deacetylated. Indeed, we
found that the histone deacetylase inhibitor TSA, caused a
dramatic increase in COMMD1 levels, which was independent of
XIAP (Fig. 3C).
These data confirm that acetylation plays an important role in
regulating COMMD1 stability and suggest that under basal
conditions, COMMD1 is continuously acetylated and deactylated,
which limits the rate of XIAP-mediated ubiquitylation and
degradation.
p300-mediated acetylation of COMMD1 is required for RelA
binding in response to aspirin and is induced in a stimuli-
specific manner
Throughout the course of these studies, we observed a reduction
in XIAP in response to aspirin, which leads to increased amounts
of COMMD1. Therefore, it could be argued that the effects of
aspirin are dependent on XIAP and independent of p300. To
further address the role of p300, we utilised the fact that knocking
down p300 and XIAP together results in substantial levels of
COMMD1 that, if p300 is the crucial acetyltransferase, should not
be acetylated (Fig. 3A). We found that, as predicted, p300 loss
abrogated aspirin-mediated COMMD1 acetylation (Fig. 4A). We
also found that the interaction between RelA and COMMD1,
detected in cells transfected with control and XIAP siRNA, was
completely lost when p300 was depleted, despite substantial
COMMD1 levels (see Fig. 4A, lane 8). These data, which were
confirmed in an independent cell line (Fig. 4A), reveal that p300
is required for aspirin-mediated acetylation of COMMD1 and that
this is essential for nucleolar translocation of RelA not only to
stabilise COMMD1, but also to enable a RelA–COMMD1
interaction. In contrast to aspirin, we observed a minimal
increase in COMMD1–p300 binding or in COMMD1
acetylation in response to TNF (Fig. 4B,C).
Taken together, our data suggest the model outlined in Fig. 4D.
We suggest acetylation blocks XIAP-mediated ubiquitylation
of COMMD1 and, consequently, the rate of acetylation and
deacetylation which determines the steady-state levels of the
protein. We propose that this dynamic is altered upon exposure to
specific stress stimuli, resulting in increased COMMD1–p300
binding and increased levels of acetylated protein. We propose
Fig. 3. COMMD1 acetylation and deacetylation protects against XIAP-
mediated degradation. (A) SW480 cells were transfected with control, p300
and XIAP siRNA, either individually or together. Western blotting (WB) was
performed on whole cell lysates. Actin controlled for loading. COMMD1
levels are depleted by p300 knockdown but rescued by concomitant
knockdown of XIAP. (B) Cells were transfected with GST–COMMD1
alongside control or XIAP siRNA. COMMD1 was isolated and the level of
acetylated (Ac) COMMD1 was determined as in Fig. 2. Input levels of XIAP
confirm knockdown. (C) Cells were not treated (NT) or treated with aspirin
(5 mM) or trichostatin A (TSA, 400 nM) for 16 h. The western blot shows
COMMD1 and XIAP levels.
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that the acetylated form of COMMD1 recruits a unique ubiquitin
ligase complex that ubiquitylates RelA with a signature that
drives it to the nucleolus to mediate apoptosis (Khandelwal et al.,
2011), rather than to the proteasome.
In support of our suggestion that aspirin and TNF recruit
different ubiquitin ligase complexes, it has been shown that
phosphorylation at S468 (Geng et al., 2009; Mao et al., 2009) and
methylation at K314 and K315 (Yang et al., 2009) are crucial for
Fig. 4. See next page for legend.
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TNF-mediated ubiquitylation and degradation of RelA, whereas
we have shown that deleting the C-terminus of RelA does not
affect aspirin-mediated ubiquitylation or nucleolar translocation
of the protein (our unpublished data; Stark and Dunlop, 2005).
Furthermore, we found that calyculin A promotes S468 and/or
S536 phosphorylation while blocking aspirin and MG132-
mediated RelA ubiquitylation (Thoms et al., 2010). The
ubiquitin ligase complex that ubiquitylates RelA in response to
TNF, and the pattern of this ubiquitylation has been well defined
(Li et al., 2012; Mao et al., 2009). Our data open up new avenues
of research into the RelA ubiquitylation signature that targets the
protein to the nucleolus, and the ubiquitin ligase complex
associated with p300-acetylated COMMD1.
Aspirin-mediated stabilisation of COMMD1 in biopsies of
human tumours
Aspirin acts as a chemopreventative agent against colorectal
cancer (Din et al., 2010). To determine the relevance of our
findings to this activity, we treated biopsies of fresh colorectal
tumours with pharmacological doses of the agent ex vivo
(Fig. 4E; supplementary material Fig. S1). We found that 1 h
aspirin (100 mM) treatment induced an increase in COMMD1
levels in three out of four tumours. We also found that aspirin
caused an increase in COMMD1 levels in the pre-tumorigenic
AA/C1 cell line (Fig. 4F) and its tumorigenic equivalent AA/C1/
SB10 (Fig. 4A) (Williams et al., 1990). Based on these findings
and our previous studies, we suggest that stabilisation of
COMMD1, through p300-mediated acetylation, is important for
the chemopreventative activity of the agent.
MATERIALS AND METHODS
Cell lines and reagents
Human SW480 colon cancer cells (American Type Culture Collection)
and those expressing GFP–RelA (SW480-GFP-RelA) were grown as
described previously (Thoms et al., 2010). AA/C1 and AAC1/SB10 cells
were a gift from Ann C. Williams (School of Molecular and Cellular
Medicine, University of Bristol, UK). Aspirin and trichostatin A (TSA)
(Sigma) were prepared as described previously (Loveridge et al., 2008).
TNF (R&D Systems) was used as specified in the text.
Plasmids and transfections
The GFP–RelA expression construct was gifted by Eva Qwarnstrom
(University of Sheffield, UK), the His6-Ubiquitin (Ub) plasmid by
Ronald T. Hay (University of Dundee, UK) the GST–COMMD1 vector
plus control by Erza Burstein (Ann Arbor Medical Centre, MI) (Maine
et al., 2007) and the p300WT and DHAT plasmids by Kathryn Ball
(University of Edinburgh, UK) (Dornan et al., 2004). siRNA species used
were as follows: p300a (CAGAGCAGUCCUGGAUUAGUU), p300b
(Santa Cruz Biotechnology) and XIAP (Santa Cruz Biotechnology).
Plasmid and siRNA transfections were carried out using Lipofectamine
2000 (Gibco, BRL) according to the manufacturer’s instructions.
Immunoprecipitations
Immunoprecipitations for GST–COMMD1 and His6–Ub were performed
on whole-cell lysates (Thoms et al., 2010).
Western blot analysis
Whole-cell extracts were prepared and immunoblots performed on 30 mg
of extract using standard procedures (Thoms et al., 2010). Primary
antibodies were: rabbit anti-p65 (C-20) (Santa Cruz), mouse anti-p65
(Santa Cruz Biotechnology), rabbit anti-p65 (acetyl K310) (Abcam),
mouse anti-His (generated in house), mouse anti-p300 (BD Pharmingen),
rabbit anti-acetylated lysine (Cell Signaling), mouse anti-COMMD1
(Abnova), anti-XIAP (Santa Cruz) and anti-GST–HRP (Abcam)
antibodies. Actin (Amersham) controlled for protein loading.
Immunocytochemical staining
Cells were fixed in 1:1 methanol:acetone (220 C˚), then immunocytochemistry
was performed using standard procedures. Primary antibodies were against
p65 (rabbit polyclonal, C20) and mouse monoclonal, C23 (both Santa Cruz
Biotechnology). Fluorescent microscopy was performed with a Zeiss
Axioplan microscope, a 636Plan Neofluor objective and a Chroma 83,000
filter set. Images were captured using IPLab Spectrum 3.6. The percentage
of cells showing nucleolar RelA was determined in .200 cells from more
than five fields of view in three independent experiments or as specified.
Quantitative PCR
Total RNA was isolated from cells using TRIzol (Invitrogen) then cDNA
generated using a 1st Strand cDNA synthesis kit (Roche). The Roche
TaqMan COMMD1 assay and the reference gene, GAPDH, were used with
a LightCycler 480 system (Roche) to quantify cDNA. The Pfaffl method was
used for relative quantitation of the target and reference gene transcripts.
Site-directed mutagenesis and live-cell imaging
GFP–RelAWT was mutated at the specified lysine residues using the
QuikChange site-directed mutagenesis kit (Stratagene) with specific
primers. The sequence of all constructs was confirmed. An Axiovert 100
inverted microscope (Zeiss) determined the localisation of GFP-tagged
proteins in live cells. Images were captured and processed using IPLab
3.6 with scripts written in-house.
Ex vivo treatment of colorectal tumour biopsies
These studies were undertaken with patient consent and full ethical
approval according to the Declaration of Helsinki (2000) (Scottish
Colorectal Cancer Genetic Susceptibility Study 3; Reference, 11/SS/
0109). Details in supplementary material Fig. S1.
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Fig. 4. p300-mediated acetylation of COMMD1 is stimuli specific and is
required for RelA binding in response to stress. (A–C) SW480 or AA/C1/
SB10 cells were transfected with GST–COMMD1 alone (B,C) or with the
siRNA species indicated (A). Cells were treated with aspirin (Asp) (10 mM) or
TNF (10 ng/ml) for 2 h prior to harvest. GST–COMMD1 was
immunoprecipitated (IP) as in Fig. 2, then isolated proteins were subjected to
western blotting (WB) with the antibodies indicated. Input levels of the
proteins of interest are shown. (D) Model for the role of acetylation in
regulating the steady state levels of COMMD1 and the ubiquitylation and
nucleolar translocation of RelA. See discussion for details. AC, acetylation;
ub, ubiquitylation. (E) Tumour biopsies from four colorectal cancer
patients were exposed to pharmacological doses of aspirin (100 mM, 1 h) ex
vivo (see supplementary material Fig. S1). Western blot showing
COMMD1 levels in whole-cell lysates. The asterisks indicate biopsies where
COMMD1 increases in response to aspirin. (F) Western blot showing
effects of aspirin (10 mM) on COMMD1 levels in the pre-tumorigenic AA/C1
cell line.
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Supplemental gure 1. Aspiirin eects on COMMD1 levels in biopsies of human 
tumours. Biopsies of colorectal tumours were provided by a pathologist at the 
time of resection. All patients were consented and full ethical approval was in 
place (Scottish Colorectal Cancer Genetic Susceptibility Study 3;  Reference: 
11/SS/0109).  Biopsies were immediately transferred to the lab immersed in 
culturing media (MEM supplemented with glutamine, penicillin/streptomycin 
and anti-mycotic/antibiotic mix (1:100, Sigma). Tumours were placed in Falcon 
tubes containing sterile PBS, washed twice by inverting the tubes, and then 
placed in Petri dishes containing sterile culturing media and dissected into 
1-2mm2 fragments. They were then transferred to new Petri dishes and washed 
with fresh media before plating. Treatment (0-100µM aspirin, 1h, 37oC) of tumour 
explants was performed in 96-well plates and in the presence of 10% foetal calf 
serum.  Whole cell extracts were prepared from tumour tissue using a TissueLyser
 (Qiagen) and standard whole cell lysis buer.  
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